SC refuses plea seeking Centre to approach ICJ against China for Covid-19

The plea, filed by Madurai resident K K Ramesh, had alleged that Covid-19 has been "deliberately created by China as biological weapon against India"

Coronavirus: SC refuses to hear plea for directing Centre to move ICJ for compensation from China
Press Trust of India New Delhi
2 min read Last Updated : Jun 18 2020 | 3:30 PM IST
The Supreme Court Thursday refused to entertain a plea seeking direction to the Centre to approach the International Court of Justice (ICJ) and file a USD 600 billion compensation case against China, alleging that the Covid-19 pandemic was "deliberately created" by it.

A bench comprising Chief Justice S A Bobde and Justices Dinesh Maheshwari and A S Bopanna said it would not entertain PIL which claimed there was strong evidence that coronavirus or Covid-19, which has "destroyed" the Indian economy and killed hundreds of it citizens, originated from China's Wuhan Institute of Virology.

Advocate C R Jaya Sukin, appearing for the petitioner, told the bench that the plea should be treated as a representation by the government.


The plea, filed by Madurai resident K K Ramesh, had alleged that Covid-19 has been "deliberately created by China as biological weapon against India".

"Petitioner states Covid-19 pandemic was designed by China to be a very effective and catastrophic biological warfare weapon to kill mass population in India," said the plea.

It underlined that coronavirus spread in India, other countries and continents but not in other cities of China despite originating in nearby Wuhan.

The plea said that since individuals cannot approach the ICJ, the Centre should be directed to file the compensation case against China.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusSupreme Court

Next Story